NASDAQ:INM | Income Statement | InMed Pharmaceuticals Inc.

Complete source-backed income-statement history.

Available history
2019-09-30 to 2026-03-31
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-03-31$1.02M$2.84M-$2.79M-$2.97M-$0.73-$0.734,048,2094,048,209
2025-12-31$820,188.00$635,994.00$184,194.00$630,636.00$2.29M-$2.03M-$2.03M-$0.51-$0.513,954,5493,954,549
2025-09-30$1.12M$716,962.00$403,159.00$581,612.00$2.22M-$1.73M-$1.73M-$0.44-$0.443,954,5493,954,549
2025-06-30$1.3M$728,056.00$576,654.00$609,972.00$3.04M-$1.31M-$1.79M-$0.43-$0.43172,076172,076
2025-03-31$1.26M$1.09M$175,625.00$425,370.00$2.08M-$2.07M-$2.12M-$1.94-$1.941,095,9731,095,973
2024-12-31$1.11M$650,813.00$460,894.00$895,176.00$2.71M-$2.58M-$2.58M-$3.64-$3.64706,546706,546
2024-09-30$1.26M$771,225.00$493,413.00$700,145.00$2.23M-$1.68M-$1.68M-$2.71-$2.71620,127620,127
2024-06-30$1.28M$816,996.00$466,071.00$658,869.00$2.5M-$1.93M-$1.94M-$3.66-$3.6632,95632,956
2024-03-31$1.17M$883,143.00$289,458.00$656,764.00$2.13M-$1.72M-$1.72M-$3.58-$3.58480,649480,649
2023-12-31$1.24M$745,584.00$324,142.00$609,791.00$1.97M-$1.48M-$1.48M-$3.71-$3.71398,673398,673
2023-09-30$901,862.00$787,690.00$21,242.00$1.29M$2.69M-$2.54M-$2.54M-$2.54M-$15.24-$15.24166,410166,410
2023-06-30-$458,741.00$1.32M$1.57M$623,744.00$2.13M-$338,391.00-$336,591.00-$338,391.00$0.28$0.28292,175292,175
2023-03-31$1.03M$841,414.00$192,511.00$878,303.00$2.34M-$2M-$2M-$2M-$0.60-$0.603,328,1913,328,191
2022-12-31$469,783.00$338,620.00$131,163.00$851,356.00$2.35M-$2.1M-$2.1M-$2.1M-$0.91-$0.912,300,5262,300,526
2022-09-30$320,788.00$235,034.00-$491,018.00$1.38M$3.08M-$3.51M-$3.5M$6,800.00-$3.51M-$4.06-$4.06865,619865,619
2022-06-30$791,078.00$265,044.00$249,714.00$1.5M$6.77M-$7.87M-$7.87M-$7.87M-$13.04-$13.0427,75927,759
2022-03-31$309,585.00$127,308.00$182,277.00$1.75M$3.72M-$3.48M-$3.48M-$3.48M-$6.14-$6.14566,062566,062
2021-12-31$265,092.00$153,537.00$111,555.00$2.54M$4.42M-$4.28M-$4.28M-$4.28M-$7.73-$7.73553,894553,894
2021-09-30$1.49M$2.89M-$2.97M-$2.97M-$2.97M-$6.17-$6.17481,902481,902
2021-06-30$880,634.00$1.72M$3.31M-$3.26M-$3.26M-6,009,031
2021-03-31$437,309.00$1.77M$3.13M-$3.1M-$3.1M7,549,040
2020-12-31$276,790.00$937,948.00$1.93M-$2.24M-$2.24M6,091,359
2020-09-30$911,156.00$1.56M-$1.6M5,220,707
2020-06-30$967,610.00$1.56M-$1.62M0
2020-03-31$1.27M$2.2M-$2.02M5,220,707
2019-12-31$1.61M$2.51M-$2.49M5,220,707
2019-09-30$1.96M$2.88M-$2.81M5,220,707

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-06-30$4.94M$3.24M$1.71M$2.85M$9.65M-$8.16M-$8.16M-$8.36-$8.36975,985975,985
2024-06-30$4.6M$3.5M$1.1M$3.22M$9.3M$527,901.00-$7.67M$7,100.00-$7.68M-$20.14-$20.14381,053381,053
2023-06-30$1.37M$2.73M$1.4M$3.73M$9.83M-$7.95M$492,440.00-$7.93M$13,100.00-$7.95M-$3.25-$3.252,448,4582,448,458
2022-06-30$1.37M$545,889.00$543,546.00$7.28M$17.81M-$18.6M-$18.6M-$18.6M-$33.17-$33.17560,829560,829
2021-06-30$1.9M$5.34M$9.94M-$10.2M-$10.2M-$37.96-$37.96268,793268,793
2020-06-30$5.81M$9.15M-$8.94M5,220,707